###begin article-title 0
###xml 19 25 19 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
###xml 27 35 27 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKN2A/B</italic>
###xml 37 44 37 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IGF2BP2</italic>
###xml 46 53 46 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC30A8</italic>
###xml 59 67 59 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HHEX/IDE</italic>
Common Variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, and HHEX/IDE Genes Are Associated With Type 2 Diabetes and Impaired Fasting Glucose in a Chinese Han Population
###end article-title 0
###begin p 1
###xml 34 49 34 49 <email xmlns:xlink="http://www.w3.org/1999/xlink">xlin@sibs.ac.cn</email>
Corresponding author: Dr. Xu Lin, xlin@sibs.ac.cn
###end p 1
###begin p 2
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See  for details.
###end p 2
###begin p 3
###xml 0 10 0 10 <bold xmlns:xlink="http://www.w3.org/1999/xlink">OBJECTIVE&#8212;</bold>
###xml 78 84 78 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
###xml 86 94 86 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKN2A/B</italic>
###xml 96 103 96 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IGF2BP2</italic>
###xml 105 112 105 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC30A8</italic>
###xml 114 122 114 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HHEX/IDE</italic>
###xml 124 128 124 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EXT2</italic>
###xml 134 143 134 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LOC387761</italic>
OBJECTIVE- Genome-wide association studies have identified common variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, HHEX/IDE, EXT2, and LOC387761 loci that significantly increase the risk of type 2 diabetes. We aimed to replicate these observations in a population-based cohort of Chinese Hans and examine the associations of these variants with type 2 diabetes and diabetes-related phenotypes.
###end p 3
###begin p 4
###xml 0 28 0 28 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESEARCH DESIGN AND METHODS&#8212;</bold>
###xml 130 142 <span type="species:ncbi:9606">participants</span>
RESEARCH DESIGN AND METHODS- We genotyped 17 single nucleotide polymorhisms (SNPs) in 3,210 unrelated Chinese Hans, including 424 participants with type 2 diabetes, 878 with impaired fasting glucose (IFG), and 1,908 with normal fasting glucose.
###end p 4
###begin p 5
###xml 0 8 0 8 <bold xmlns:xlink="http://www.w3.org/1999/xlink">RESULTS&#8212;</bold>
###xml 81 87 81 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
###xml 125 126 125 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 138 140 138 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;7</sup>
###xml 146 154 146 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKN2A/B</italic>
###xml 174 175 174 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 186 188 186 188 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;3</sup>
###xml 238 245 238 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IGF2BP2</italic>
###xml 265 266 265 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 280 287 280 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC30A8</italic>
###xml 307 308 307 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 365 371 365 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
###xml 373 380 373 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IGF2BP2</italic>
###xml 386 393 386 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC30A8</italic>
###xml 561 567 555 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
###xml 579 587 573 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKN2A/B</italic>
###xml 600 607 594 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IGF2BP2</italic>
###xml 623 630 617 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC30A8</italic>
###xml 695 696 689 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 708 710 702 704 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;7</sup>
###xml 762 763 756 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 775 778 769 772 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;11</sup>
###xml 801 805 795 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EXT2</italic>
###xml 809 818 803 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LOC387761</italic>
###xml 931 939 925 933 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HHEX/IDE</italic>
###xml 1000 1001 994 995 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1042 1043 1036 1037 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
RESULTS- We confirmed the associations between type 2 diabetes and variants near CDKAL1 (odds ratio 1.49 [95% CI 1.27-1.75]; P = 8.91 x 10-7) and CDKN2A/B (1.31 [1.12-1.54]; P = 1.0 x 10-3). We observed significant association of SNPs in IGF2BP2 (1.17 [1.03-1.32]; P = 0.014) and SLC30A8 (1.12 [1.01-1.25]; P = 0.033) with combined IFG/type 2 diabetes. The SNPs in CDKAL1, IGF2BP2, and SLC30A8 were also associated with impaired beta-cell function estimated by homeostasis model assessment of beta-cell function. When combined, each additional risk allele from CDKAL1-rs9465871, CDKN2A/B-rs10811661, IGF2BP2-rs4402960, and SLC30A8-rs13266634 increased the risk for type 2 diabetes by 1.24-fold (P = 2.85 x 10-7) or for combined IFG/type 2 diabetes by 1.21-fold (P = 6.31 x 10-11). None of the SNPs in EXT2 or LOC387761 exhibited significant association with type 2 diabetes or IFG. Significant association was observed between the HHEX/IDE SNPs and type 2 diabetes in individuals from Shanghai only (P < 0.013) but not in those from Beijing (P > 0.33).
###end p 5
###begin p 6
###xml 0 12 0 12 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CONCLUSIONS&#8212;</bold>
###xml 75 81 75 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
###xml 83 91 83 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKN2A/B</italic>
###xml 93 100 93 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IGF2BP2</italic>
###xml 106 113 106 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC30A8</italic>
CONCLUSIONS- Our results indicate that in Chinese Hans, common variants in CDKAL1, CDKN2A/B, IGF2BP2, and SLC30A8 loci independently or additively contribute to type 2 diabetes risk, likely mediated through beta-cell dysfunction.
###end p 6
###begin p 7
Published ahead of print at  on 15 July 2008.
###end p 7
###begin p 8
Y.W. and H.L. contributed equally to this article.
###end p 8
###begin p 9
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
###end p 9
###begin p 10
###xml 247 248 247 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r1">1</xref>
###xml 601 602 601 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r2">2</xref>
###xml 603 604 603 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r3">3</xref>
###xml 657 662 657 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PPARG</italic>
###xml 664 670 664 670 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KCNJ11</italic>
###xml 676 682 676 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2</italic>
###xml 1080 1081 1080 1081 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r4">4</xref>
###xml 1082 1083 1082 1083 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r6">6</xref>
###xml 141 147 <span type="species:ncbi:9606">people</span>
The rapid increase in prevalence of type 2 diabetes has been a major public health challenge worldwide, including China. The total number of people with diabetes in China is estimated to increase from 20.8 million in 2000 to 42.3 million in 2030 (1). Besides the important contribution of environmental factors, including changes in dietary patterns and lifestyle, genetic determinants also play a major role in type 2 diabetes susceptibility. Over the past decade, serious efforts have been put into the search for type 2 diabetes susceptibility genes, but progress has been slower than anticipated (2,3). Although common variants in a few genes including PPARG, KCNJ11, and TCF7L2 have been convincingly replicated in individuals with European ancestry, relatively few studies have been conducted in Chinese, and, so far, no variants have been unambiguously confirmed as diabetes susceptibility loci in Chinese. However, recent advances in genome-wide association studies (GWASs) have revived the initial optimism and accelerated the discovery of diabetes susceptibility genes (4-6).
###end p 10
###begin p 11
###xml 69 75 69 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TCF7L2</italic>
###xml 200 201 200 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r7">7</xref>
###xml 350 357 347 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC30A8</italic>
###xml 491 494 488 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IDE</italic>
###xml 523 528 520 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KIF11</italic>
###xml 565 569 562 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HHEX</italic>
###xml 685 689 682 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EXT2</italic>
###xml 750 759 747 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LOC387761</italic>
###xml 801 802 798 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 803 805 800 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 866 873 863 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC30A8</italic>
###xml 878 886 875 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HHEX/IDE</italic>
###xml 1071 1077 1068 1074 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
###xml 1102 1106 1099 1103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDK5</italic>
###xml 1162 1170 1159 1167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKN2A/B</italic>
###xml 1232 1237 1229 1234 <sup xmlns:xlink="http://www.w3.org/1999/xlink">INK4a</sup>
###xml 1245 1250 1242 1247 <sup xmlns:xlink="http://www.w3.org/1999/xlink">INK4b</sup>
###xml 1259 1266 1256 1263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IGF2BP2</italic>
###xml 1291 1296 1288 1293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IGF-2</italic>
###xml 1526 1527 1520 1521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r5">5</xref>
###xml 1528 1529 1522 1523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r7">7</xref>
###xml 1530 1531 1524 1525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 1532 1534 1526 1528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 1535 1537 1529 1531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r15">15</xref>
###xml 1730 1732 1724 1726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r16">16</xref>
###xml 1733 1735 1727 1729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r18">18</xref>
The first GWAS, conducted in a French case-control cohort, confirmed TCF7L2 as a major type 2 diabetes susceptibility gene and identified four novel loci consistently associated with type 2 diabetes (7). These loci are located in chromosomal regions that harbor several genes involved in beta-cell function or development, including a variant in the SLC30A8 (zinc transporter solute carrier family 30 member 8) gene, variants located in a linkage disequilibrium (LD) block that contains the IDE (insulin-degrading enzyme), KIF11 (kinesin family member 11), and the HHEX (hematopoietically expressed homeobox) genes, as well as variants in another LD block that contains genes encoding EXT2 (exostosin 2). A fourth locus mapped to a hypothetical gene LOC387761 on chromosome 11. Four subsequent GWASs (8-12), performed in European case-control studies, confirmed the SLC30A8 and HHEX/IDE genes as type 2 diabetes susceptibility loci. Furthermore, additional variants in several new gene regions were also identified, including single nucleotide polymorhisms (SNPs) in the CDKAL1 gene, which encodes the CDK5 regulatory subunit associated protein 1-like 1; in the CDKN2A/B genes, which encode the cyclin-dependent kinase inhibitor p15INK4a and p16INK4b; in the IGF2BP2 gene, which encodes the IGF-2 mRNA binding protein 2; and a variant in a region of chromosome 11, not known to contain any genes. Most of these newly identified loci are suggested to play a role in the regulation of insulin production and beta-cell function (5,7,9,12-15). It is unclear whether these variants have the same effect in Chinese populations, which have a different genetic background and lower diabetes prevalence compared with European populations (16-18).
###end p 11
###begin p 12
Although case-control studies provide a useful design for the discovery of susceptibility loci, they are limited in providing insight into the mechanisms through which genetic variants exert their effect on the risk of type 2 diabetes. Population-based cohort studies with detailed measures of diabetes-related traits, however, might unravel the physiopathology that underlies the association between the newly discovered genetic variants and diabetes. The purpose of this study is to examine whether these novel variants are individually or collectively associated with type 2 diabetes and related traits in a population-based Chinese Han cohort including 3,210 unrelated individuals from Beijing and Shanghai.
###end p 12
###begin title 13
RESEARCH DESIGN AND METHODS
###end title 13
###begin p 14
###xml 259 261 259 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r19">19</xref>
###xml 795 797 795 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r20">20</xref>
###xml 1666 1667 1666 1667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1</italic>
###xml 1810 1811 1810 1811 <italic xmlns:xlink="http://www.w3.org/1999/xlink">2</italic>
###xml 2614 2616 2611 2613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r21">21</xref>
###xml 2853 2860 2850 2857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t1">Table 1</xref>
###xml 55 58 <span type="species:ncbi:9606">men</span>
###xml 69 74 <span type="species:ncbi:9606">women</span>
###xml 277 289 <span type="species:ncbi:9606">participants</span>
###xml 410 422 <span type="species:ncbi:9606">participants</span>
###xml 559 571 <span type="species:ncbi:9606">participants</span>
###xml 669 681 <span type="species:ncbi:9606">participants</span>
###xml 1108 1120 <span type="species:ncbi:9606">participants</span>
###xml 1166 1178 <span type="species:ncbi:9606">participants</span>
###xml 1226 1238 <span type="species:ncbi:9606">participants</span>
###xml 1254 1260 <span type="species:ncbi:9606">people</span>
###xml 1353 1365 <span type="species:ncbi:9606">participants</span>
###xml 1469 1475 <span type="species:ncbi:9606">person</span>
###xml 1554 1566 <span type="species:ncbi:9606">participants</span>
###xml 1572 1575 <span type="species:ncbi:9606">men</span>
###xml 1895 1907 <span type="species:ncbi:9606">participants</span>
###xml 2666 2678 <span type="species:ncbi:9606">participants</span>
The study sample consisted of 3,210 individuals (1,423 men and 1,787 women) from the Study on Nutrition and Health of Aging Population in China. The study population, design, and protocols of this population-based cohort study have been previously described (19). Briefly, all participants were unrelated Chinese Hans, aged 50-70 years, with at least 20 years residence in Beijing or Shanghai. Among them, 424 participants had type 2 diabetes (267 had previously diagnosed type 2 diabetes and 157 had screen-detected and treatment-naive type 2 diabetes), 878 participants had impaired fasting glucose (IFG) (all 878 were screen detected and treatment naive), and 1,908 participants had normal fasting glucose (NFG). Type 2 diabetes was defined by either 1999 World Health Organization criteria (20) or previously diagnosed type 2 diabetes. NFG and IFG were defined as fasting glucose <5.6 mmol/l (100 mg/dl) and 5.6 mmol/l (100 mg/dl) less than or equal to fasting glucose <7.0mmol/l (126 mg/dl), respectively. The study was conducted simultaneously in both Beijing and Shanghai from March to June 2005. The participants were recruited from two urban districts (400 participants for each district) and one rural district (800 participants), representing people with high to low socioeconomic status, using a multistage sampling method in each city. All participants were selected randomly from the eligible candidates listed in the residential registration record. One person from each household was allowed to participate, and at least 40% of the total participants were men in each district. Individuals with the following conditions were excluded from the study: 1) severe psychological disorders, physical disabilities, cancer, cardiovascular disease, Alzheimer's disease, or dementia, within 6 months; or 2) currently diagnosed with tuberculosis, AIDS, and other communicable diseases. All participants attended a physical examination, during which standard anthropometric measurements and overnight fasting blood samples were collected. Glucose was measured enzymatically on an automatic analyzer (Hitachi 7080; Hitachi, Tokyo, Japan) with reagents purchased from Wako Pure Chemical Industries (Osaka, Japan). Fasting insulin was determined by radioimmunoassay (Linco Research, St. Charles, MO). A1C concentrations were measured by turbidometric immunoassay in red blood cells on the Hitachi 7080 Analyzer using reagents from Roche Diagnostics (Indianapolis, IN). Homeostasis model assessment (HOMA) of insulin sensitivity (HOMA-S) and beta-cell function (HOMA-B) were estimated using Levy's computer model (21). Written informed consent was obtained from all participants, and study protocols were approved by the institutional review board of the Institute for Nutritional Sciences. The phenotypic characteristics of the population are shown in Table 1.
###end p 14
###begin title 15
Genotyping.
###end title 15
###begin p 16
###xml 345 346 345 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r7">7</xref>
###xml 347 349 347 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 422 428 422 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
###xml 480 488 480 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HHEX/IDE</italic>
###xml 528 532 528 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EXT2</italic>
###xml 573 581 573 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKN2A/B</italic>
###xml 609 616 609 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IGF2BP2</italic>
###xml 644 651 644 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC30A8</italic>
###xml 674 683 674 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LOC387761</italic>
###xml 855 856 855 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1008 1009 1008 1009 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1277 1278 1277 1278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1309 1313 1309 1313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HHEX</italic>
###xml 1320 1321 1320 1321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Genomic DNA was extracted from peripheral blood leukocytes by the salting-out procedure (available at ). SNP genotyping was performed with the GenomeLab SNPstream Genotyping System (Beckman Coulter), according to the manufacturer's protocol. Seventeen SNPs previously reported to be associated with type 2 diabetes by at least one of the GWASs (7-12) were successfully genotyped in our population. These include SNPs near CDKAL1 (rs10946398, rs7754840, rs7756992, and rs9465871), HHEX/IDE (rs1111875, rs5015480, and rs7923837), EXT2 (rs1113132, rs11037909, and rs3740878), CDKN2A/B (rs10811661 and rs564398), IGF2BP2 (rs4402960 and rs1470579), SLC30A8 (rs13266634) (R325W), LOC387761 (rs7480010), and an intergenic SNP (rs9300039) in chromosome 11. The genotyping success rate was >97.1%, and the concordance rate was >99% based on 12% duplicate samples (n = 384). Samples with ambiguous base calling were genotyped again. Genotype frequencies of all 17 SNPs were consistent with Hardy-Weinberg equilibrium (P > 0.01), and most of the minor allele frequencies observed in this study were comparable with those in the HapMap CHB (Chinese Han in Beijing) sample (online appendix Table 1 [available at ]). Genotypic distributions were similar in Beijing and Shanghai populations (P > 0.05), except for the three HHEX SNPs (P = 0.041, 0.003, and 0.005 for rs1111875, rs5015480, and rs7923837, respectively).
###end p 16
###begin title 17
Statistical analyses.
###end title 17
###begin p 18
###xml 465 466 465 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1005 1013 1005 1013 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HHEX/IDE</italic>
###xml 1020 1021 1020 1021 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1104 1105 1104 1105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 391 403 <span type="species:ncbi:9606">Participants</span>
###xml 1090 1102 <span type="species:ncbi:9606">participants</span>
Hardy-Weinberg equilibrium was tested using a likelihood ratio test. LD between SNPs was estimated using Haploview version 3.2 (available at ). The association between each SNP and the risk of type 2 diabetes and IFG was examined using logistic regression. Generalized linear regression was applied to study the associations between each SNP and type 2 diabetes-related quantitative traits. Participants with known diabetes or receiving glucose-lowering treatment (n = 267) were excluded from the type 2 diabetes-related quantitative trait analyses. All association analyses assumed an additive effect of the risk allele and were adjusted for sex, age, BMI (where appropriate), and geographical region (Shanghai versus Beijing). BMI, insulin, and HOMA-S were log transformed before analyses, and the data were presented as geometric means. Likelihood ratio tests were used to examine genotype distribution in Beijing and Shanghai. Because of a significant difference in genotype distribution of the three HHEX/IDE SNPs (P < 0.05) and in diabetes prevalence between the Shanghai and Beijing participants (P < 0.0001), analyses for these SNPs were performed for Shanghai and Beijing separately.
###end p 18
###begin p 19
###xml 735 736 735 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Q</italic>
###xml 1015 1016 1015 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r7">7</xref>
###xml 1017 1019 1017 1019 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 305 317 <span type="species:ncbi:9606">participants</span>
###xml 388 400 <span type="species:ncbi:9606">Participants</span>
Gene-gene interactions were assessed by including the respective interaction terms of pairwise SNPs in logistic regressions using the maximum likelihood estimation. The combined effect of multiple SNPs on the risk of type 2 diabetes and/or IFG was determined by logistic regression after categorizing the participants into groups according to the number of the risk alleles they carried. Participants with one or no risk alleles served as the reference group. Bonferroni correction was used to adjust for multiple testing in the quantitative trait analyses. Association analyses were performed with SAS version 9.1 (SAS Institute, Cary, NC). Meta-analyses were conducted with Stata (version 9.2; Stata, College Station, TX). Cochran's Q test was performed to assess heterogeneity among different groups. Power calculations were performed using Quanto software (available at ), and the power shown in online appendix Table 1 was calculated for association between each SNP and type 2 diabetes using the odds ratios (7-12) reported in the original studies and sample size and minor allele frequencies in our own study.
###end p 19
###begin title 20
RESULTS
###end title 20
###begin p 21
###xml 76 83 76 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t2">Table 2</xref>
###xml 95 101 95 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
###xml 130 131 130 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 131 132 131 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 309 310 309 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 321 323 321 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;5</sup>
###xml 387 388 387 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 404 412 404 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKN2A/B</italic>
###xml 510 511 510 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 573 574 573 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 586 588 586 588 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;5</sup>
###xml 602 610 602 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKN2A/B</italic>
###xml 664 665 664 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 665 666 665 666 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 762 769 762 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IGF2BP2</italic>
###xml 771 772 771 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 772 773 772 773 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 790 797 790 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC30A8</italic>
###xml 911 912 911 912 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
We first examined the association with the risk of type 2 diabetes and IFG (Table 2). The four CDKAL1 SNPs spanned two LD blocks (r2 = 1.0 for rs7754840 and rs10946398 and 0.96 for rs7756992 and rs9465871) and were each significantly associated with type 2 diabetes (odds ratios ranged between 1.38 and 1.49; P < 1.9 x 10-5) and with combined IFG/type 2 diabetes (between 1.20 and 1.22; P < 0.0013). The CDKN2A/B rs10811661 variant was also associated with type 2 diabetes (odds ratio 1.31 [95% CI 1.12-1.54]; P = 0.001) and combined IFG/type 2 diabetes (1.26 [1.13-1.41]; P = 2.76 x 10-5). The second CDKN2A/B SNP (rs564398), which was not in LD with rs10811661 (r2 = 0), was not associated with type 2 diabetes or combined type 2 diabetes/IFG. The two SNPs in IGF2BP2 (r2 = 0.83) and the SLC30A8 SNP (rs13266634) showed modest association with combined IFG/type 2 diabetes (odds ratios between 1.12 and 1.17; P = 0.013-0.033) but not with type 2 diabetes alone.
###end p 21
###begin p 22
###xml 10 14 10 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EXT2</italic>
###xml 45 46 45 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 46 47 46 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 220 221 220 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">r</italic>
###xml 221 222 221 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 317 325 317 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HHEX/IDE</italic>
###xml 553 560 553 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t2">Table 2</xref>
###xml 573 581 573 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HHEX/IDE</italic>
###xml 846 847 846 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 872 873 872 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 650 662 <span type="species:ncbi:9606">participants</span>
The three EXT2 variants were in complete LD (r2 = 1.0) and occurred less frequently in our population (58%) than in European populations (70%). These variants, as well as those in chromosome 11 (rs7480010 and rs9300039, r2 = 0.037), were not associated with type 2 diabetes or IFG. Analyses for the three SNPs in the HHEX/IDE LD block were performed separately in Shanghai and Beijing populations, as the difference in genotype distribution and prevalence of type 2 diabetes and IFG could lead to spurious associations due to population stratification (Table 2). All three HHEX/IDE SNPs were significantly associated with type 2 diabetes in Shanghai participants, with rs5015480 and rs7923837 also associated with combined IFG/type 2 diabetes. Meta-analyses suggested that the associations exhibited significant heterogeneity for SNPs rs1111875 (P = 0.006) and rs5015480 (P = 0.028) between Beijing and Shanghai populations.
###end p 22
###begin p 23
###xml 286 293 286 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t3">Table 3</xref>
###xml 507 515 507 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKN2A/B</italic>
###xml 531 540 531 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LOC387761</italic>
###xml 561 567 561 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
###xml 613 614 613 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 648 649 648 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 809 810 809 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 849 856 849 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC30A8</italic>
###xml 973 974 973 974 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1034 1035 1034 1035 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1070 1076 1070 1076 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
###xml 1104 1111 1104 1111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IGF2BP2</italic>
###xml 1205 1206 1205 1206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
We next examined the association between genetic variants and type 2 diabetes-related quantitative traits (glucose, A1C, insulin, HOMA-B, HOMA-S, and BMI) to investigate whether these variants conferred risk of type 2 diabetes through their effects on any of these intermediate traits (Table 3). Consistent with the case-control analyses, the SNPs that showed significant evidence for association with diabetes-related phenotypes were those that were also associated with type 2 diabetes or IFG, except for CDKN2A/B rs10811661 and LOC387761 rs7480010. All four CDKAL1 SNPs were significantly associated with A1C (P values 0.036-0.0096) and HOMA-B (P values 0.024-0.0009). The SNPs (rs7756992 and rs9465871) in the second LD block of this locus also showed significant association with fasting glucose levels (P < 0.04). Interestingly, the allele of SLC30A8 SNP rs13266634 that increases the risk of combined IFG/type 2 diabetes was significantly associated with lower BMI (P = 0.0087) and marginally associated with decreased HOMA-B (P = 0.05). Only the associations of CDKAL1-rs10946398, rs7754840, and IGF2BP2-rs4402960 with HOMA-B remained significant after Bonferroni correction for multiple testing (P = 0.0014, 0.05/36 tests).
###end p 23
###begin p 24
###xml 44 50 44 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
###xml 154 160 154 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
###xml 244 245 244 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 289 295 287 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
To examine whether the associations for the CDKAL1 variants were independent, we performed additional multiple regression analyses that included all four CDKAL1 SNPs in one model. Results showed that none of the four SNPs remained significant (P >/= 0.17). Next, we tested whether the two CDKAL1 "pairs" (rs7754840 and rs7756992 were chosen to represent each of the pairs) were independent from each other for the associations with type 2 diabetes or related quantitative traits in multiple regression models with both rs7754840 and rs7756992 genotypes in the model, with age, sex, region, and BMI (where appropriate) as covariates. The results revealed that the association seems to be driven by rs7754840, for the associations with type 2 diabetes, BMI, and HOMA-B, or by rs7756992, for the association with A1C, but interestingly, rs7754840 and rs7756992 seem to have independent effects on the associations with HOMA-S or insulin (online appendix Table 2).
###end p 24
###begin p 25
###xml 87 89 87 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 90 92 90 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r22">22</xref>
###xml 172 174 172 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r25">25</xref>
###xml 243 249 243 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
###xml 254 262 254 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKN2A/B</italic>
###xml 380 388 380 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKN2A/B</italic>
###xml 484 485 484 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 574 575 574 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 588 590 588 590 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;6</sup>
###xml 600 606 600 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
###xml 720 722 720 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r25">25</xref>
We also performed a meta-analysis with the data from the previously published studies (10-12), including those from Japanese, Korean, and Hong Kong Chinese populations (22-25), to assess the heterogeneity between Caucasians and Asians for the CDKAL1 and CDKN2A/B loci (rs7754840 and rs10811661 were chosen to represent each of them, respectively). The results showed that for the CDKN2A/B loci (rs10811661), the heterogeneity between Caucasians and Asians did not reach significance (P = 0.059), while a significant heterogeneity was observed between Caucasians and Asians (P = 8.872 x 10-6) for the CDKAL1 loci (rs7754840) (online appendix Fig. 1), and this is consistent with the recent finding reported by Ng et al. (25).
###end p 25
###begin p 26
###xml 54 63 54 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LOC387761</italic>
###xml 213 214 213 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 355 363 355 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKN2A/B</italic>
###xml 525 529 525 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EXT2</italic>
Although we did not observe the association among the LOC387761 SNP rs7480010 and type 2 diabetes or IFG, we found that the allele that increased the diabetes risk in European populations was modestly associated (P < 0.03) with increased insulin sensitivity (HOMA-S) and lower fasting insulin levels. Furthermore, despite a strong association between the CDKN2A/B SNP rs10811661 and type 2 diabetes, no association was observed with any of the diabetes-related quantitative traits. The intergenic SNP rs9300039 and the three EXT2 SNPs (rs3740878, rs11037909, and rs1113132) were not associated with any of the diabetes-related quantitative traits.
###end p 26
###begin p 27
###xml 148 154 148 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
###xml 156 164 156 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKN2A/B</italic>
###xml 166 173 166 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IGF2BP2</italic>
###xml 179 186 179 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC30A8</italic>
###xml 350 351 350 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 344 351 344 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 456 457 456 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 469 471 469 471 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;7</sup>
###xml 480 481 480 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 474 481 474 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 530 531 530 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 543 546 543 546 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;11</sup>
###xml 555 556 555 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 549 556 549 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>C</italic></xref>
###xml 666 667 666 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 676 678 676 678 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 735 736 735 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 729 736 729 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 865 866 865 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 883 884 883 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 877 884 877 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>D</italic></xref>
###xml 895 896 895 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 912 913 912 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 906 913 906 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>E</italic></xref>
###xml 952 953 952 953 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 965 967 965 967 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;7</sup>
###xml 976 977 976 977 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 970 977 970 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>F</italic></xref>
###xml 1082 1083 1082 1083 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 1094 1096 1094 1096 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;3</sup>
###xml 1105 1106 1105 1106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 1099 1106 1099 1106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1<italic>F</italic></xref>
###xml 1165 1171 1165 1171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
###xml 1176 1183 1176 1183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC30A8</italic>
###xml 1199 1206 1199 1206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="t3">Table 3</xref>
###xml 231 243 <span type="species:ncbi:9606">participants</span>
###xml 321 333 <span type="species:ncbi:9606">participants</span>
###xml 559 571 <span type="species:ncbi:9606">Participants</span>
###xml 753 765 <span type="species:ncbi:9606">participants</span>
###xml 989 1001 <span type="species:ncbi:9606">participants</span>
We found no evidence of multiplicative gene-gene interactions among the main SNPs (rs9465871, rs10811661, rs4402960, and rs13266634) in each of the CDKAL1, CDKN2A/B, IGF2BP2, and SLC30A8 genes. A significantly higher proportion of participants with type 2 diabetes carry increasing numbers of risk alleles, compared with participants with NFG (Fig. 1A). In combined analysis, each additional risk allele increased the risk of type 2 diabetes by 1.24-fold (P = 2.85 x 10-7) (Fig. 1B) and combined IFG/type 2 diabetes by 1.21-fold (P = 6.31 x 10-11) (Fig. 1C). Participants harboring seven or all eight risk alleles had a 4.44-fold increased risk for type 2 diabetes (P = 5 x 10-4) compared with those with one or no risk alleles (Fig. 1B). Consistently, participants with increasing numbers of risk alleles tended to have increased fasting levels of plasma glucose (P = 0.013) (Fig. 1D) and A1C (P = 0.07) (Fig. 1E), as well as decreased HOMA-B values (P = 3.34 x 10-7) (Fig. 1F). Of note, participants with increasing numbers of risk alleles tended to have significantly lower BMI (P = 5.3 x 10-3) (Fig. 1F), which is consistent with previous results found for the CDKAL1 and SLC30A8 polymorphisms (Table 3).
###end p 27
###begin title 28
DISCUSSION
###end title 28
###begin p 29
###xml 158 159 158 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r7">7</xref>
###xml 160 162 160 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 177 183 177 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
###xml 185 193 185 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKN2A/B</italic>
###xml 195 202 195 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IGF2BP2</italic>
###xml 204 211 204 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC30A8</italic>
###xml 217 221 217 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HHEX</italic>
###xml 348 354 348 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
###xml 359 366 359 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IGF2BP2</italic>
In this study of Chinese Hans, we replicated associations with several diabetes susceptibility variants recently identified through GWASs in white Europeans (7-12). Variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, and HHEX loci were significantly associated with the risk of type 2 diabetes or combined IFG/type 2 diabetes. Furthermore, variants in CDKAL1 and IGF2BP2 were strongly associated with beta-cell function estimated by HOMA-B.
###end p 29
###begin p 30
###xml 24 30 24 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
###xml 180 181 168 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 182 184 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 185 187 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 220 226 208 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
###xml 410 416 398 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
###xml 576 577 564 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 590 592 578 580 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;6</sup>
###xml 611 617 599 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="f1" ref-type="fig">Fig. 1</xref>
###xml 686 687 674 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 736 742 724 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
###xml 867 873 855 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
###xml 999 1005 984 990 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
###xml 1267 1273 1249 1255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
###xml 1741 1742 1723 1724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 1743 1745 1725 1727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r13">13</xref>
###xml 1746 1748 1728 1730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r26">26</xref>
###xml 1764 1770 1746 1752 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
The risk alleles of the CDKAL1 variants increased diabetes risk by approximately1.4-fold. These associations were stronger than those observed in individuals of European Ancestry (8-10,12) (online appendix Table 1), and CDKAL1 risk allele frequencies are also substantially higher in Chinese (43-55%) than Europeans (15-31%). Moreover, significant heterogeneity between Caucasians and Asians was found for the CDKAL1 loci (rs7754840) in the meta-analysis that combined the data from the previous studies in white Europeans, Japanese, Korean, Hong Kong Chinese, and our study (P = 8.872 x 10-6) (online appendix Fig. 1), while no significant heterogeneity was observed among the Asians (P = 0.369). These observations suggest that these CDKAL1 variants might play an even more important role in diabetes susceptibility in Chinese. The risk allele of the first pair of CDKAL1 variants was strongly associated with reduced beta-cell function (HOMA-B) and increased A1C levels, while the second pair of CDKAL1 variants showed an association with impaired beta-cell function (HOMA-B) and higher glucose levels, as well as with increased A1C. The results from additional multiple regression analyses suggest that the four SNPs most likely represent the effects of a single CDKAL1 locus. However, none of these four SNPs stands out as being the variant driving the association. Therefore, we assume that none of them is likely to be the causal variant, but presumably they are in moderate to high LD with the causal SNP and are therefore less consistently associated with the traits of interest. This region would benefit from a detailed fine mapping to identify possible causal variants in future studies. These results support previous findings (9,13,26) that the four CDKAL1 SNPs confer the risk of type 2 diabetes through reduced insulin secretion, although the causal SNP is yet to be identified.
###end p 30
###begin p 31
###xml 49 57 49 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKN2A/B</italic>
###xml 203 205 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 206 208 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 449 450 425 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 539 547 515 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKN2A/B</italic>
###xml 571 579 547 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKN2A/B</italic>
We also observed significant association between CDKN2A/B rs10811661 and type 2 diabetes and IFG with a slightly higher odds ratio (approximately1.3) than that observed in Europeans (approximately1.20) (10-12). The risk allele is twice as prevalent in Chinese Hans (46%) as in Europeans (21%). However, we did not observed significant heterogeneity between Caucasians and Asians in the meta-analysis with data from the previously published studies (P = 0.059). Interestingly, none of the diabetes-related traits showed an association with CDKN2A/B rs10811661. The second CDKN2A/B variant, rs564398, which is less frequent in Chinese Hans (13%) than in Europeans (38%), was not associated with type 2 diabetes or any related traits.
###end p 31
###begin p 32
###xml 36 43 36 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IGF2BP2</italic>
###xml 387 388 375 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 522 529 510 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IGF2BP2</italic>
###xml 643 650 628 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC30A8</italic>
The association between variants in IGF2BP2 and type 2 diabetes was not significant, although the odds ratios were similar to those observed in European populations (approximately1.15), suggesting that our study may not have been sufficiently powered. Indeed, assuming an additive model and a minor allele frequency of 25%, we had <50% power to detect previously reported odds ratios at P < 0.05. We did, however, find a significant association with combined IFG/type 2 diabetes. The associations with HOMA-B suggest that IGF2BP2 confer type 2 diabetes risk through a reduced beta-cell function. Similarly, we found no association between the SLC30A8 rs13266634 variant and type 2 diabetes, while an association with combined IFG/type 2 diabetes reached borderline significance. Interestingly, the risk allele that increased diabetes risk in Europeans was also associated with a lower BMI in this population.
###end p 32
###begin p 33
###xml 92 96 92 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EXT2</italic>
###xml 249 250 237 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r7">7</xref>
###xml 349 350 337 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r7">7</xref>
###xml 461 462 449 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r8">8</xref>
###xml 463 465 451 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r12">12</xref>
###xml 477 479 465 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 480 482 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
###xml 494 496 482 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r10">10</xref>
###xml 510 511 498 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r9">9</xref>
###xml 522 524 510 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r27">27</xref>
###xml 541 543 529 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r23">23</xref>
###xml 688 690 676 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r28">28</xref>
###xml 691 693 679 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r29">29</xref>
###xml 950 959 938 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LOC387761</italic>
###xml 1180 1188 1165 1173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HHEX/IDE</italic>
We also failed to find any evidence for association between type 2 diabetes and the SNPs in EXT2 (rs3740878, rs11037909, and rs1113132) and the intergenic SNP rs9300039, despite approximately80% power to detect previously reported effect estimates (7). Although these SNPs exhibited marginal associations with type 2 diabetes in the original study (7), they were largely negative in the subsequent four GWASs and other replication studies in samples from U.K. (8,12), Finnish (10,11), Swedish (10), Icelandic (9), German (27), and Japanese (23) populations. Therefore, the original associations for these SNPs were either population specific or overestimated due to the "winner's curse" (28,29), but the consistent lack of replication suggests that these findings were more likely false-positives. Meta-analyses or studies with larger sample sizes will be required to draw definitive conclusions. Although there was no association between rs7480010 (LOC387761) and type 2 diabetes or IFG, the allele conferring risk of diabetes in Europeans was associated with increased insulin sensitivity and showed a tendency toward a reduced beta-cell function as well. For the three SNPs in HHEX/IDE gene region, the associations with type 2 diabetes or IFG were observed only in Shanghai individuals in whom each risk allele resulted in 1.45- to 1.79-fold increased diabetes risk, suggesting that geographical stratification may exist in our population for these SNPs and their roles in type 2 diabetes susceptibility. However, given the relatively small sample size, we cannot rule out sampling bias. This observation needs to be confirmed in larger studies.
###end p 33
###begin p 34
###xml 120 126 120 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
###xml 138 146 138 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKN2A/B</italic>
###xml 159 166 159 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IGF2BP2</italic>
###xml 182 190 182 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC30A8-</italic>
###xml 421 422 421 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 431 433 431 433 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 549 551 549 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="r11">11</xref>
###xml 313 325 <span type="species:ncbi:9606">participants</span>
We found no evidence of pairwise synergistic gene-gene interactions on type 2 diabetes and the related phenotypes among CDKAL1-rs9465871, CDKN2A/B-rs10811661, IGF2BP2-rs4402960, and SLC30A8-rs13266634. In joint analyses, the risk of type 2 diabetes was increased by 1.24-fold for each additional risk allele, and participants with seven or all eight risk alleles (3.8%) had a 4.44-fold increased risk of type 2 diabetes (P = 5 x 10-4) compared with those with one or no risk allele. These results are consistent with those reported by Scott et al. (11), who examined combined effects of 10 risk variants in a GWAS of European populations. Compared with Scott's study, the advantage of our study is that our data are based on the general population. However, a replication in larger population is required to examine whether combinations of risk alleles from these variants have good predictive and diagnostic potential in Chinese Hans.
###end p 34
###begin p 35
###xml 81 87 81 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
###xml 92 100 92 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKN2A/B</italic>
###xml 138 145 138 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC30A8</italic>
###xml 150 157 150 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IGF2BP2</italic>
###xml 333 339 330 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
###xml 341 349 338 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKN2A/B</italic>
###xml 351 358 348 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IGF2BP2</italic>
###xml 364 371 361 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC30A8</italic>
In conclusion, we replicated the association of type 2 diabetes with the SNPs in CDKAL1 and CDKN2A/B genes and confirmed that the SNPs in SLC30A8 and IGF2BP2 were associated with the risk of combined IFG/type 2 diabetes. Most of these SNPs were also associated with the impaired beta-cell function. Importantly, the risk variants in CDKAL1, CDKN2A/B, IGF2BP2, and SLC30A8 appear to act in an additive manner to increase the risk of type 2 diabetes and related phenotypes. These results provide solid evidence for the notion that these variants individually or collectively contribute to the risk of type 2 diabetes in the Chinese Han population, possibly by impairing beta-cell function or reducing insulin secretion.
###end p 35
###begin title 36
Supplementary Material
###end title 36
###begin title 37
Online-Only Appendix
###end title 37
###begin p 38
This study was funded by research grants from the National Natural Science Foundation of China (30571562), a grant from the Knowledge Innovation Program Pilot Project of the Chinese Academy of Sciences (KSCX2-YW-R-73), the National Basic Research Program of China (973 program no. 2006CB503902), the Major Projects of Knowledge Innovation Program (KSCX2-YW-R-116 and KSCX1-YW-02), and the Shanghai-Unilever Research Development Fund (CH-2006-0941).
###end p 38
###begin p 39
###xml 23 35 <span type="species:ncbi:9606">participants</span>
We are grateful to all participants of the Nutrition and Health of Aging Population in China. We also thank our colleagues at the laboratory and the local Centers for Disease Control and Prevention staff of Beijing and Shanghai for their assistance with data collection.
###end p 39
###begin title 40
REFERENCES
###end title 40
###begin p 41
###xml 64 70 64 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKAL1</italic>
###xml 82 90 82 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKN2A/B</italic>
###xml 103 110 103 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IGF2BP2</italic>
###xml 126 133 126 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SLC30A8</italic>
###xml 146 147 146 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 389 390 358 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 402 404 371 373 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;7</sup>
###xml 407 408 376 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 457 458 426 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 470 473 439 442 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;11</sup>
###xml 476 477 445 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 480 481 449 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 590 591 559 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 600 602 569 571 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;4</sup>
###xml 765 766 734 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 777 778 746 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 789 790 758 759 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 800 801 769 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 840 841 809 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 853 855 822 824 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;7</sup>
###xml 858 859 827 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 876 877 845 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 888 890 857 859 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;3</sup>
###xml 893 894 862 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 944 945 913 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
###xml 955 956 924 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink">G</italic>
###xml 185 197 <span type="species:ncbi:9606">participants</span>
###xml 211 223 <span type="species:ncbi:9606">participants</span>
###xml 483 495 <span type="species:ncbi:9606">Participants</span>
###xml 653 665 <span type="species:ncbi:9606">participants</span>
Combined effects of increasing numbers of the risk alleles from CDKAL1-rs9465871, CDKN2A/B-rs10811661, IGF2BP2-rs4402960, and SLC30A8-rs13266634. A: The risk allele distribution in the participants with NFG and participants with type 2 diabetes. square, control; blacksquare, square, filled, type 2 diabetes. Each additional risk allele increased the risk of type 2 diabetes by 1.24-fold (P = 2.85 x 10-7) (B) and of IFG and diabetes combined by 1.21-fold (P = 6.31 x 10-11) (C). B: Participants harboring seven or all eight risk alleles had a 4.44-fold increased risk for type 2 diabetes (P = 5 x 10-4) compared with the reference group. Consistently, participants with increasing numbers of risk alleles tended to have increased fasting levels of plasma glucose (P = 0.013) (D) and A1C (P = 0.07) (E), as well as decreased HOMA-B values (P = 3.34 x 10-7) (F) and lower BMI (P = 5.3 x 10-3) (H), but showed no association with plasma insulin (P = 0.13) (G).
###end p 41
###begin p 42
Characteristics of the study population
###end p 42
###begin p 43
###xml 56 57 54 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 91 92 89 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Data are means +/- SD, median (interquartile range), or n (%), unless otherwise indicated. P represents significance of the differences between individuals from Beijing and from Shanghai.
###end p 43
###begin p 44
Associations with type 2 diabetes or IFG and type 2 diabetes combined
###end p 44
###begin p 45
###xml 55 56 55 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Odds ratios represent the effects of risk alleles. The P values were adjusted for age, sex, BMI, and region (where appropriate).
###end p 45
###begin p 46
Alleles in bold are the risk alleles for type 2 diabetes identified by previous studies, while alleles underlined are the risk alleles for type 2 diabetes or IFG observed in this study. All analyses were based on an additive model, in which individuals homozygous for the nonrisk alleles were coded as 0, heterozygous individuals were coded as 1, and individuals homozygous for the risk alleles were coded as 2.
###end p 46
###begin p 47
Associations with type 2 diabetes-related quantitative traits
###end p 47
###begin p 48
Data are means +/- SE or
###end p 48
###begin p 49
geometric means +/- SE, unless otherwise indicated. Alleles in bold are the risk alleles for type 2 diabetes identified by previous studies while alleles underlined are the risk alleles for type 2 diabetes or IFG observed in this study.
###end p 49
###begin p 50
Adjusted for age, sex, region, and BMI.
###end p 50
###begin p 51
Adjusted for age, sex, and region.
###end p 51
###begin p 52
###xml 122 123 122 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
The associations remained significant after Bonferroni correction for multiple tests, and the Bonferroni corrected cutoff P value is 0.0014 (0.05/36 tests).
###end p 52

